Straight answers
Ipamorelin questions, answered plainly and cited
The questions people actually ask — about risks, side effects, the CJC-1295 stack, and how long it lasts.
What are the risks of ipamorelin?
The biggest risk is the unknown: there's no long-term human safety data, and the only sizeable trial (114 patients, 7 days IV) missed its endpoint without flagging an ipamorelin-specific danger in that short window [3]. Named concerns are class-level: a related ghrelin-receptor drug caused heart-muscle damage in rats over 28 days [6], and GH-driven IGF-1 raises theoretical cancer concerns [1].
What are the downsides of ipamorelin?
The honest downsides: efficacy is unproven in humans — its one Phase 2 trial failed (25.3 h vs 32.6 h placebo, p=0.15) [3] — and the long-term safety record is essentially blank [3]. Reported side effects include flushing, puffiness, tingling, and more hunger after injecting (all anecdotal) [1]. Supply is also gray-market and unverified for purity [3].
Does ipamorelin cause cancer?
There is no evidence that ipamorelin causes cancer, and no human study has tested it either way [3]. The concern is purely theoretical: growth hormone raises IGF-1, a mitogen that pushes cells to grow, so chronically boosting GH could in principle accelerate a pre-existing tumor [1]. That's a mechanism-based caution for people with active or recent cancer — not an observed finding in any ipamorelin study [1][3].
What are the side effects of CJC-1295 and ipamorelin?
Reported side effects of the CJC-1295 + ipamorelin combination (all anecdotal, not from a controlled trial of the pair) include facial flushing and head-rush after injecting, tingling in hands and feet, mild water retention, increased hunger, lightheadedness, and injection-site redness [1]. The combination has never been safety-tested in a human trial, so these come from community reports, not study data [3].
Does ipamorelin affect cortisol or prolactin?
No — and that's its signature feature. In its founding characterization ipamorelin released GH potently but did not raise ACTH, cortisol, or prolactin even at doses more than 200-fold above its GH threshold in rats and pigs [1]. This selectivity is exactly what distinguishes it from the older peptides GHRP-6 and GHRP-2, which do stimulate cortisol and prolactin [1].
What is ipamorelin?
Ipamorelin is a synthetic five-amino-acid peptide (sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2) that activates the ghrelin receptor GHS-R1a to release a pulse of growth hormone [1]. It was the first highly selective GH secretagogue, meaning it raises GH without raising cortisol or prolactin [1]. It is a research compound, never approved as a drug for any indication [3].
What does ipamorelin do for you?
In studies, ipamorelin triggers a discrete pulse of your own growth hormone by acting on the ghrelin receptor [1]. People who use it research-style report better sleep and faster recovery (anecdotal) [1]. But its one human efficacy trial failed [3], so "what it does for you" in any proven clinical sense is unestablished — the demonstrated action is a short-term GH pulse, peaking near 40 minutes [2].
What is ipamorelin peptide?
"Ipamorelin peptide" is just the full name for ipamorelin — a wholly synthetic pentapeptide (five-amino-acid chain) that mimics the hunger hormone ghrelin at the GHS-R1a receptor to release growth hormone [1]. Its molecular weight is about 712 daltons, and non-natural amino acids make it resistant to enzyme breakdown [1]. It is not a hormone your body makes; it borrows ghrelin's receptor [1].
Does ipamorelin reduce belly fat?
No human study has measured ipamorelin reducing belly fat. The relevant data is animal: in a 2024 ferret study, ipamorelin (1–3 mg/kg) cut chemotherapy-induced body-weight loss by about 24% via a peripheral mechanism [5]. Some users anecdotally report a gradual leaner look over weeks to months, but that's confounded by diet and training and is not a clinical finding [5].
Why is ipamorelin being discontinued?
Ipamorelin was never an approved drug, so it isn't being "discontinued" in the usual sense — its clinical development simply stopped after its only Phase 2 trial (for postoperative ileus) missed its primary endpoint in 2014 [3]. Separately, in 2024 the FDA removed ipamorelin acetate from Category 2 of the interim 503A bulk-substances list, tightening compounding-pharmacy access — a regulatory restriction, not a product recall.
What does CJC-1295 and ipamorelin do?
Together, CJC-1295 (a GHRH analog) and ipamorelin (a ghrelin-receptor peptide) push growth hormone release through two complementary pathways [1]. A 2026 review found the combination improved muscle tetanic tension in a mouse muscle-loss model — but stressed the evidence is animal-only [11]. There is no human trial of the pair for any outcome [3].
Does ipamorelin increase IGF-1?
Indirectly and inconsistently. Growth hormone drives the liver to make IGF-1, so sustained GH elevation can raise it — but short rodent ipamorelin studies often show no measurable IGF-1 change. A 15-day rat bone-growth study found dose-dependent bone effects with no change in total IGF-1 [4], suggesting some effects are local and GH-pulse-driven rather than IGF-1-mediated [4].
How does CJC-1295 ipamorelin work?
CJC-1295 mimics growth-hormone-releasing hormone (GHRH) and acts on the GHRH receptor; ipamorelin mimics ghrelin and acts on GHS-R1a [1]. Because these are two different receptors and signaling routes, the two peptides stimulate GH release through complementary mechanisms — the rationale for combining them [1]. CJC-1295 sustains the signal; ipamorelin adds a pulse on top [1].
How much CJC-1295 ipamorelin should I take?
There's no evidence-based dose to give — the combination has never been dosed in a controlled human trial for any outcome [3]. Forum "stack" protocols are anecdotal, unvalidated, and not recommended here. What the literature supports is the mechanism (two complementary GH-release pathways), not any specific human dose [1]. This site reports research doses only, never recommendations [3].
Does CJC-1295 ipamorelin work?
Only animal evidence exists. A 2026 orthopaedic review reported the CJC-1295 + ipamorelin combination improved maximal muscle tetanic tension in a mouse glucocorticoid-induced muscle-loss model, while explicitly noting the evidence is limited to animal studies [11]. Ipamorelin alone reliably raises GH short-term [1], but no controlled human outcome trial of the combination exists [3].
How to reconstitute CJC-1295 ipamorelin 5mg?
This site doesn't provide preparation steps. In general research-supply terms, ipamorelin ships as a lyophilized (freeze-dried) powder reconstituted with bacteriostatic water, and being a peptide it degrades with heat and freeze-thaw, so solution is kept refrigerated [2]. These are handling observations, not instructions for human use — ipamorelin is not an approved drug and has no clinical reconstitution protocol [3].
How long does ipamorelin stay in your system?
Ipamorelin's terminal half-life in humans is about 2 hours, so it's largely cleared from the blood within roughly 8–10 hours [2]. The GH pulse it triggers peaks near 40 minutes and is brief [2]. Detection is a separate matter: anti-doping labs can flag GH secretagogues by urine test well beyond blood clearance [11]. See the how long does ipamorelin stay in your system page for the full breakdown.
Does ipamorelin make you hungry?
It can, because ipamorelin acts on the ghrelin receptor — ghrelin is the body's hunger hormone [1]. Some users report a noticeable uptick in appetite in the hours after injecting (anecdotal), generally described as milder than with GHRP-6 [1]. Ghrelin-receptor agonists are known to switch on the brain's appetite centers and drive feeding in studies [14].
Will I gain weight on ipamorelin?
No human study answers this directly. Mechanistically, ipamorelin can increase appetite (ghrelin-receptor action) [14] and showed GH-independent stimulation of fat gain in mice [13], so weight change is plausible and direction-dependent on intake. Some users report a leaner look over time (anecdotal, confounded by diet) [5], others a hungry spell after injecting [1]. There's no clinical weight-outcome data [3].
Does ipamorelin increase appetite?
It can. Ipamorelin activates the ghrelin (GHS-R1a) receptor, and ghrelin-receptor agonists are shown to induce feeding by activating brain appetite centers [14]. Community reports describe increased hunger after injecting, generally milder than GHRP-6 (anecdotal) [1]. The appetite effect is a recognized class-level property of ghrelin mimetics, not a quirk of one batch [14].
What does ipamorelin peptide do?
Ipamorelin peptide triggers a discrete pulse of growth hormone by selectively activating the ghrelin receptor GHS-R1a, without raising cortisol or prolactin [1]. In humans that GH pulse peaks around 40 minutes after IV dosing [2]. Rodent work shows downstream effects like increased longitudinal bone growth [4], but its one human efficacy trial (for postoperative ileus) failed [3].
How long does it take for ipamorelin to work?
Fast, at the hormonal level: the growth hormone pulse ipamorelin triggers peaks around 40 minutes after IV dosing as a single discrete burst [2]. That's the measured pharmacodynamic onset. Any subjective effects people report — like sleep changes — are anecdotal and described over one to two weeks, not from controlled trials [1]. The acute GH response, though, is rapid and well-characterized [2].